Remdesivir Discontinuation Decisions Based on Thresholds of Aminotransferase in an Observational Registry.

In this descriptive study of real-world practice in the USA, clinicians are overall making more conservative treatment decisions than are recommended for consideration in approved drug labeling of discontinuation, with wide variation in the aminotransferase thresholds being used.